BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 3088722)

  • 21. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
    Perl A; Looney RJ; Ryan DH; Abraham GN
    J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
    Ostensen ME; Thiele DL; Lipsky PE
    J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remission.
    Dabholkar M; Tatake R; Amin K; Advani S; Gangal S
    Oncology; 1989; 46(2):123-7. PubMed ID: 2785254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of interferons in neuroblastoma. 2: Immunomodulatory effects].
    Handgretinger R; Bruchelt G; Daurer B; Lang P; Dopfer R; Reisfeld RA; Treuner J; Niethammer D
    Klin Padiatr; 1990; 202(4):206-11. PubMed ID: 2118581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential neutralizing activity of human antibodies in interferon antiviral and natural killer cell bioassays.
    Thurmond LM; Reese MJ
    J Interferon Cytokine Res; 1997 Oct; 17(10):619-23. PubMed ID: 9355963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
    Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M
    Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
    Sung MW; Johnson JT; Van Dongen G; Whiteside TL
    Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2.
    Svedersky LP; Shepard HM; Spencer SA; Shalaby MR; Palladino MA
    J Immunol; 1984 Aug; 133(2):714-8. PubMed ID: 6203975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K; Kuribayashi K; Saito K
    Cancer Immunol Immunother; 1989; 29(2):79-86. PubMed ID: 2497980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of interferon and tumour necrosis factor by cloned human natural cytotoxic lymphocytes and T cells.
    Christmas SE; Meager A; Moore M
    Clin Exp Immunol; 1987 Aug; 69(2):441-50. PubMed ID: 2443292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of interferons on the inhibition of human natural killers by primary monolayer cell cultures.
    Heiskala M
    Immunology; 1987 Feb; 60(2):167-72. PubMed ID: 2434416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon is able to reduce tumor cell susceptibility to human lymphokine-activated killer (LAK) cells.
    Grönberg A; Ferm M; Tsai L; Kiessling R
    Cell Immunol; 1989 Jan; 118(1):10-21. PubMed ID: 2463094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of natural killer cell activation and antibody-dependent cellular cytotoxicity by interferon-alpha and interleukin-12 in vaginal mucosae Sivmac251-infected Macaca fascicularis.
    Poaty-Mavoungou V; Touré FS; Tevi-Benissan C; Mavoungou E
    Viral Immunol; 2002; 15(1):197-212. PubMed ID: 11952142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.
    Neighbour PA; Grayzel AI; Miller AE
    Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-West Nile virus activity of in vitro expanded human primary natural killer cells.
    Zhang M; Daniel S; Huang Y; Chancey C; Huang Q; Lei YF; Grinev A; Mostowski H; Rios M; Dayton A
    BMC Immunol; 2010 Jan; 11():3. PubMed ID: 20089143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-induced resistance to the killing by NK cells: a preferential effect of IFN-gamma.
    Wallach D
    Cell Immunol; 1983 Feb; 75(2):390-5. PubMed ID: 6403252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates.
    Nair MP; Schwartz SA; Menon M
    Cell Immunol; 1985 Aug; 94(1):159-71. PubMed ID: 3926326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of human alpha and gamma interferon on mixed lymphocyte culture and on T-cell-mediated cytotoxicity. Inhibition of proliferation but not of IL-2 production by alpha interferons.
    Chae F; Oleszak E; Fox FE; Trotta P; Mele CA; Hawrylko E; Platsoucas CD
    Int Arch Allergy Appl Immunol; 1988; 86(4):361-9. PubMed ID: 2970436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.